Sr. Manager, RDBU L&P, Training Lead - TAVNEOS & Dazodalibep (DAZ)

Role: Lead Learning & Performance strategy for Amgen’s Rare Disease Business Unit, focusing on TAVNEOS and upcoming launch of dazodalibep (DAZ) for Sjögren’s disease. Responsibilities: develop and execute training programs, onboarding, sales capability initiatives, and cross-functional launch readiness activities; partner with Brand, Medical, Marketing, and Commercial teams; support global launch planning and curriculum development; potentially lead and develop team members as the organization grows. Requirements: Bachelor’s degree with 6+ years of sales training or related experience; or equivalent combination including advanced degrees. Preferred: expertise in instructional design, curriculum development, vendor management, and experience supporting biopharma product launches; ability to influence senior stakeholders and manage multiple strategic initiatives in a matrix environment. High-Value: US-based remote position with approximately 30% travel; focus on rare diseases, immunology, and launch readiness for biologics or specialty therapies; cross-functional collaboration with global teams; strategic emphasis on capability-building for current and future product launches.